Deutsch English Français

Contact

EP1015477

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1015477

EP1015477 - 32 Human secreted proteins [Right-click to bookmark this link]
Former [2000/27]	32 HUMAN SECRETED PROTEINS
	[2010/13]
Status	No opposition filed within time limit Status updated on 16.09.2011 Database last updated on 24.08.2024
Most recent event Tooltip	16.09.2011	No opposition filed within time limit	published on 19.10.2011 [2011/42]
Applicant(s)	For all designated states HUMAN GENOME SCIENCES, INC. 14200 Shady Grove Road Rockville, MD 20850 / US
	[2010/50]
Former [2010/21]	For all designated states HUMAN GENOME SCIENCES, INC. 9410 Key West Avenue Rockville, MD 20850 / US
Former [2000/27]	For all designated states HUMAN GENOME SCIENCES, INC. 9410 Key West Avenue Rockville, MD 20878 / US
Inventor(s)	01 / RUBEN, Steven, M. 18528 Heritage Hills Drive Olney, MD 20832 / US
	02 / ROSEN, Craig, A. 22400 Rolling Hill Road Laytonsville, MD 20882 / US
	03 / CARTER, Kenneth, C. 11601 Brandy Hall Lane North Potomac, MD 20878 / US
	04 / DILLON, Patrick, J. 1055 Snipe Court Carlsbad, CA 92009 / US
	05 / ENDRESS, Gregory, A. 9729 Clagett Farm Drive Potomac, MD 20854 / US
	06 / YU, Guo-Liang 13524 Straw Bale Lane Darnestown, MD 20878 / US
	07 / NI, Jian 5502 Manorfield Road Rockville, MD 20853 / US
	08 / FENG, Ping 4 Relda Court Gaithersburg, MD 20878 / US
	[2000/27]
Representative(s)	Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
	[N/P]
Former [2008/35]	Vossius & Partner Siebertstrasse 3 81675 München / DE
Former [2000/27]	VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE
Application number, filing date	98926105.2	28.05.1998
	[2000/27]
	WO1998US10868
Priority number, date	US19970044039P	30.05.1997 Original published format: US 44039 P
	US19970048093P	30.05.1997 Original published format: US 48093 P
	US19970048190P	30.05.1997 Original published format: US 48190 P
	US19970050935P	30.05.1997 Original published format: US 50935 P
	US19970048101P	30.05.1997 Original published format: US 48101 P
	US19970048356P	30.05.1997 Original published format: US 48356 P
	US19970056250P	29.08.1997 Original published format: US 56250 P
	US19970056296P	29.08.1997 Original published format: US 56296 P
	US19970056293P	29.08.1997 Original published format: US 56293 P
	[2000/27]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9854206
	Date:	03.12.1998
	Language:	EN
	[1998/48]
	Type:	A1 Application with search report
	No.:	EP1015477
	Date:	05.07.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.12.1998 takes the place of the publication of the European patent application.
	[2000/27]
	Type:	B1 Patent specification
	No.:	EP1015477
	Date:	10.11.2010
	Language:	EN
	[2010/45]
Search report(s)	International search report - published on:	US	03.12.1998
	(Supplementary) European search report - dispatched on:	EP	16.04.2004
Classification	IPC:	C07K14/525	[2010/13]
	CPC:	C07K14/47 (EP,US); C07K14/525 (EP,US); A61K38/00 (EP,US); G01N2500/04 (EP,US)
	Former IPC [2004/22]	C07K14/47
	Former IPC [2000/27]	C07K1/00, C07H21/04
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/27]
Title	German:	32 Humane sekretierte Proteine	[2010/13]
	English:	32 Human secreted proteins	[2010/13]
	French:	32 Protéines humaines sécrétées	[2010/13]
	Former [2000/27]	32 DURCH MENSCHEN AUSGESCHÜTTETE PROTEINE
	Former [2000/27]	32 HUMAN SECRETED PROTEINS
	Former [2000/27]	32 PROTEINES SECRETEES PAR L'HOMME
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	07.12.1999	National basic fee paid
	07.12.1999	Search fee paid
	07.12.1999	Designation fee(s) paid
	07.12.1999	Examination fee paid
Examination procedure	22.12.1998	Request for preliminary examination filed International Preliminary Examining Authority: US
	07.12.1999	Examination requested [2000/27]
	21.05.2003	Amendment by applicant (claims and/or description)
	06.05.2005	Despatch of a communication from the examining division (Time limit: M06)
	10.11.2005	Reply to a communication from the examining division
	01.06.2006	Despatch of a communication from the examining division (Time limit: M04)
	29.09.2006	Reply to a communication from the examining division
	12.06.2007	Despatch of a communication from the examining division (Time limit: M06)
	21.12.2007	Reply to a communication from the examining division
	25.04.2008	Despatch of a communication from the examining division (Time limit: M06)
	28.10.2008	Reply to a communication from the examining division
	04.05.2009	Cancellation of oral proceeding that was planned for 26.05.2009
	15.05.2009	Despatch of a communication from the examining division (Time limit: M06)
	26.05.2009	Date of oral proceedings
	26.05.2009	Date of oral proceedings (cancelled)
	24.11.2009	Reply to a communication from the examining division
	04.05.2010	Communication of intention to grant the patent
	14.09.2010	Fee for grant paid
	14.09.2010	Fee for publishing/printing paid
Divisional application(s)	EP10180663.6 / EP2332975
Opposition(s)	11.08.2011	No opposition filed within time limit [2011/42]
Fees paid	Renewal fee
	04.05.2000	Renewal fee patent year 03
	04.05.2001	Renewal fee patent year 04
	21.05.2002	Renewal fee patent year 05
	26.05.2003	Renewal fee patent year 06
	24.05.2004	Renewal fee patent year 07
	19.05.2005	Renewal fee patent year 08
	30.05.2006	Renewal fee patent year 09
	30.05.2007	Renewal fee patent year 10
	28.05.2008	Renewal fee patent year 11
	27.05.2009	Renewal fee patent year 12
	25.05.2010	Renewal fee patent year 13
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO9718235 (RECH DE PATHOLOGIE APPL SOC D [FR], et al) [A] 20-23 * page 1, line 12 - line 15 *;
		[E]WO9855508 (SAGAMI CHEM RES [JP], et al) [E] 1-11 * page 152 - page 153 *;
		[PX] - DO RICKE ET AL, "Sequencing of human chromosome 16p13.3", EMBL_HUMAN, (19980505), XP002275989 [PX] 1-5 * nucleotides 18350-18960 correspond to nucleotides 1000-390 in SEQ ID NO:23 *
	International search	[X]WO9531544 (YEDA RES & DEV [IL], et al);
		[X] - HILLIER L, ET AL, "yx39a08.sl Homo Sapiens cDNA Clone 264086 3", MPSRCH GENBANK, (19000101), Database accession no. N20562, XP002913637
		[X] - HILLIER L, ET AL, "yw43d02.sl Homo Sapiens cDNA Clone 254979 3", MPSRCH GENBANK, (19000101), Database accession no. N23080, XP002913638
		[X] - HUDSON T, "Human STS WI-16915", MPSRCH GENBANK, (19000101), Database accession no. G23170, XP002913639
		[X] - HILLIER L, ET AL, "yn47d01.sl Homo Sapiens cDNA Clone 171553 3", MPSRCH GENBANK, (19000101), Database accession no. H18098, XP002913640
		[X] - HILLIER L, ET AL, "yy72g09.sl Homo Sapiens cDNA Clone 279136 3", MPSRCH GENBANK, (19000101), Database accession no. N46256, XP002913641
		[X] - HILLIER L, ET AL, "yx38f03.rl Homo Sapiens cDNA Clone 264029 5", MPSRCH GENBANK, (19000101), Database accession no. N28611, XP002913642
		[X] - HILLIER, ET AL, "yj81c08.rl Homo Sapiens cDNA Clone 155150 5", MPSRCH GENBANK, (19000101), Database accession no. R70283, XP002913643
		[X] - HILLIER, ET AL, "ye56e07.sl Homo Sapiens cDNA Clone 121764 3", EMBL NUCLEOTIDE SEQU, (19000101), Database accession no. T98012, XP002913644
		[X] - "H. Sapiens Partial cDNA Sequence; Clone 27b07, mRNA Sequence", MPSRCH GENBANK, (19000101), Database accession no. Z44692, XP002913645
		[X] - MARRA M, ET AL, "mf25e5.rl Soares Mouse Embryo NbME13.5 14.5 Mus Musculus cDNA Clone 406112 5, mRNA Sequence", MPSRCH GENBANK, (19000101), Database accession no. W83277, XP002913646
	Examination	WO0145730
		- LONG YIN ET AL., "Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (2004), vol. 122, pages 1175 - 1179, XP002632321
		- JEFFREY A. WINKLES ET AL., "TWEAK and Fn14: New molecular targets for cancer therapy?", CANCER LETTERS, (2006), vol. 235, pages 11 - 17
	by applicant	US4631211
		- POSTTRANSLATIONAL COVALENT MODIFICATION OF PROTEINS, ACADEMIC PRESS, (1983), pages 1 - 12
		- SEIFTER ET AL., METH ENZYMOL, (1990), vol. 182, pages 626 - 646
		- RATTAN ET AL., ANN NY ACAD SCI, (1992), vol. 663, pages 48 - 62
		- SMITH; JOHNSON, GENE, (1988), vol. 67, pages 31 - 40
		- MCGEOCH, VIRUS RES., (1985), vol. 3, pages 271 - 286
		- VON HEINJE, NUCLEIC ACIDS RES., (1986), vol. 14, pages 4683 - 4690
		- HENRIK NIELSEN ET AL., PROTEIN ENGINEERING, (1997), vol. 10, pages 1 - 6
		- BRUTLAG ET AL., COMP. APP. BIOSCI., (1990), vol. 6, pages 237 - 245
		- DOBELI, J. BIOTECHNOLOGY, (1988), vol. 7, pages 199 - 216
		- GAYLE, J. BIOL. CHEM, (1993), vol. 268, pages 22105 - 22111
		- BOWIE, J. U. ET AL., SCIENCE, (1990), vol. 247, pages 1306 - 1310
		- CUNNINGHAM; WELLS, SCIENCE, (1989), vol. 244, pages 1081 - 1085
		- PINCKARD ET AL., CLIN. EXP. IMMUNOL., (1967), vol. 2, pages 331 - 340
		- ROBBINS ET AL., DIABETES, (1987), vol. 36, pages 838 - 845
		- CLELAND ET AL., CRIT. REV. THERAPEUTIC DRUG CARRIER SYSTEMS, (1993), vol. 10, pages 307 - 377
		- GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, (1983), vol. 81, pages 3998 - 4002
		- HOUGHTEN, R. A., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 5131 - 5135
		- SCIENCE, (1997), vol. 276, pages 59 - 87

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p